| Financial Year |
March 31 2023 |
| Monetary Funds |
153,537,845.67 |
| Held-for-trading Financial Assets |
95,704,206.94 |
| Notes Receivable |
127,793,128.33 |
| Accounts Receivable |
477,975,263.19 |
| Advances to Suppliers |
20,230,447.61 |
| Other Receivables |
27,795,217.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
426,382,625.94 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,535,145.92 |
| Total Current Assets |
1,341,873,880.94 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
75,698,588.64 |
| Fixed Assetes |
249,514,489.96 |
| Under-construction Projects |
3,612,217.17 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
24,760,555.98 |
| R&D expenses |
-- |
| Goodwill |
87,689,280.76 |
| Long-Term Deferred and Prepaid Expenses |
1,170,064.19 |
| Deferred Income Tax Assets |
20,623,423.59 |
| Other Non-Current Assets |
2,986,892.34 |
| Sub-Total of Non-Current Assets |
466,685,637.77 |
| Total Assets |
1,808,559,518.71 |
| Short-Term Loans |
127,860,889.62 |
| Trading Financial liabilities |
-- |
| Notes Payable |
81,117,076.10 |
| Accounts Payable |
328,015,453.75 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,104,626.76 |
| Taxes Payable |
10,591,251.34 |
| Interest Payable |
-- |
| Dividend Payable |
200,000.00 |
| Other payables |
37,438,044.96 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,598,685.43 |
| Other Current Liabilities |
6,568,450.68 |
| Sub-Total of Current Liabilities |
624,866,113.04 |
| Long-term Loans |
36,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
885,373.08 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
44,124,051.20 |
| Total Liabilities |
668,990,164.24 |
| Paid-In Capital(Or Share Stock) |
363,909,648.00 |
| Capital Surplus |
458,939,337.41 |
| Surplus Reserve |
76,380,994.63 |
| LESS:Treasury Stock |
31,440,103.45 |
| Undistributed Profits |
188,499,888.89 |
| Minority Stockholder's Interest |
80,920,281.90 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,058,649,072.57 |
| Owner's Equity（Stockholder's Equity） |
1,139,569,354.47 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,808,559,518.71 |
